کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3358625 1591764 2015 6 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota
ترجمه فارسی عنوان
اثر زیست شناختی سفتازیدیم / آبی بکتام در میکروب بیوتای روده سالم انسان
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی میکروبیولوژی و بیوتکنولوژی کاربردی
چکیده انگلیسی


• Ceftazidime/avibactam is a new β-lactam/β-lactamase inhibitor combination.
• Ceftazidime/avibactam was given to 12 healthy volunteers.
• Ceftazidime/avibactam had a significant ecological effect on the human intestinal microbiota.
• Five volunteers were colonised by Clostridium difficile.

Ceftazidime/avibactam is a new combination of the antibiotic ceftazidime with the novel, non-β-lactam β-lactamase inhibitor avibactam. The purpose of the present study was to investigate the effect of ceftazidime/avibactam on the human intestinal microbiota following intravenous (i.v.) administration. Twelve healthy volunteers received ceftazidime/avibactam by i.v. infusion (2000 mg ceftazidime and 500 mg avibactam) given over 2 h every 8 h on Days 1–6 (inclusive) and a single dose on Day 7. Faecal samples were collected on Day–1 (pre-dose), during administration on Days 2, 5 and 7 and post-dose on Days 9, 14 and 21. Samples were cultured on non-selective and selective media. The number of Escherichia coli and other enterobacteria decreased significantly during administration of ceftazidime/avibactam, whereas the number of enterococci increased. Lactobacilli, bifidobacteria, clostridia and Bacteroides decreased significantly during ceftazidime/avibactam administration. The effects on lactobacilli, bifidobacteria and Bacteroides were similar in the 12 volunteers, whilst clostridia showed different ecological patterns among the volunteers. Toxigenic Clostridium difficile strains were detected in five volunteers during the study. In four of the volunteers, loose stools were reported as adverse events. Plasma samples were collected on Days −1, 2, 5 and 7. Ceftazidime and avibactam concentrations in plasma (ceftazidime 0–224.2 mg/L of plasma and avibactam 0–70.5 mg/L of plasma) and faeces (ceftazidime 0–468.2 mg/kg of faeces and avibactam 0–146.0 mg/kg of faeces) were found by bioassay. New colonising resistant clostridia were found in five volunteers and lactobacilli were found in three volunteers.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Antimicrobial Agents - Volume 46, Issue 1, July 2015, Pages 60–65
نویسندگان
, , , , , ,